Inversion Therapeutics
Inversion Therapeutics is a startup headquartered in Burlingame, United States, founded in 2024. It has raised at least $6.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory. Last updated .
Funding
Inversion Therapeutics has raised at least $6.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Inversion Therapeutics sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in Burlingame
Related
- Innovation profile of Burlingame
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Inversion Therapeutics do?
Inversion Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Inversion Therapeutics raised?
At least $6.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Inversion Therapeutics based?
Inversion Therapeutics is headquartered in Burlingame, United States.
When was Inversion Therapeutics founded?
Inversion Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.